Histogen Inc. (HSTOQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Dec 5, 2025
Histogen Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 |
| Cash & Equivalents | 4.57 | 12.11 | 18.69 | 6.76 | 2.07 | 3.03 | Upgrade
|
| Cash & Short-Term Investments | 4.57 | 12.11 | 18.69 | 6.76 | 2.07 | 3.03 | Upgrade
|
| Cash Growth | -68.58% | -35.19% | 176.28% | 227.51% | -31.78% | -63.00% | Upgrade
|
| Accounts Receivable | - | 0.1 | 0.17 | 0.14 | 0.11 | 0.25 | Upgrade
|
| Other Receivables | - | - | 1.06 | - | - | - | Upgrade
|
| Receivables | - | 0.1 | 1.22 | 0.14 | 0.11 | 0.25 | Upgrade
|
| Inventory | - | - | 0.14 | 0.3 | 0.11 | 0.94 | Upgrade
|
| Prepaid Expenses | 0.54 | 0.77 | 0.98 | 0.79 | 0.13 | 0.01 | Upgrade
|
| Restricted Cash | 0.3 | 0.4 | 0.4 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Other Current Assets | 0.04 | 0.08 | 0.18 | 0.4 | 0.04 | - | Upgrade
|
| Total Current Assets | 5.46 | 13.46 | 21.61 | 8.4 | 2.46 | 4.24 | Upgrade
|
| Property, Plant & Equipment | - | 5.09 | 4.83 | 4.68 | 0.42 | 0.29 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 0.71 | - | - | Upgrade
|
| Other Long-Term Assets | 0.36 | 0.52 | 0.81 | 1.22 | 0.07 | 0.22 | Upgrade
|
| Total Assets | 5.82 | 19.07 | 27.25 | 15.01 | 2.94 | 4.75 | Upgrade
|
| Accounts Payable | 0.39 | 0.38 | 1.39 | 0.54 | 0.81 | 0.32 | Upgrade
|
| Accrued Expenses | 0.94 | 0.59 | 0.78 | 0.98 | 0.44 | 0.63 | Upgrade
|
| Short-Term Debt | - | - | - | 0.19 | - | 0.01 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 0.1 | - | - | Upgrade
|
| Current Portion of Leases | - | 0.25 | 0.14 | 0.04 | 0.11 | 0.03 | Upgrade
|
| Current Unearned Revenue | 0.02 | 0.02 | 0.02 | 0.05 | 0.02 | 1.55 | Upgrade
|
| Other Current Liabilities | - | - | - | 0.89 | - | 0.52 | Upgrade
|
| Total Current Liabilities | 1.35 | 1.23 | 2.33 | 2.79 | 1.38 | 3.04 | Upgrade
|
| Long-Term Debt | - | - | - | 0.37 | - | - | Upgrade
|
| Long-Term Leases | - | 4.38 | 4.63 | 4.83 | 0.03 | 0.01 | Upgrade
|
| Long-Term Unearned Revenue | 0.07 | 0.08 | 0.1 | 0.12 | 0.14 | 0.16 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0.09 | Upgrade
|
| Total Liabilities | 1.41 | 5.7 | 7.06 | 8.1 | 1.55 | 3.29 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | - | 0.02 | Upgrade
|
| Additional Paid-In Capital | 103.12 | 102.67 | 98.84 | 70.56 | 6.86 | 6.29 | Upgrade
|
| Retained Earnings | -97.69 | -88.27 | -77.65 | -62.7 | -43.93 | -40.97 | Upgrade
|
| Total Common Equity | 5.44 | 14.41 | 21.19 | 7.86 | -37.07 | -34.66 | Upgrade
|
| Minority Interest | -1.03 | -1.03 | -1.01 | -0.95 | -0.9 | -0.86 | Upgrade
|
| Shareholders' Equity | 4.4 | 13.38 | 20.19 | 6.91 | 1.39 | 1.45 | Upgrade
|
| Total Liabilities & Equity | 5.82 | 19.07 | 27.25 | 15.01 | 2.94 | 4.75 | Upgrade
|
| Total Debt | - | 4.63 | 4.77 | 5.52 | 0.15 | 0.04 | Upgrade
|
| Net Cash (Debt) | 4.57 | 7.48 | 13.92 | 1.24 | 1.92 | 2.99 | Upgrade
|
| Net Cash Growth | -53.65% | -46.27% | 1022.42% | -35.42% | -35.74% | -41.07% | Upgrade
|
| Net Cash Per Share | 1.07 | 2.33 | 7.26 | 2.75 | 11.52 | 26.24 | Upgrade
|
| Filing Date Shares Outstanding | 4.27 | 4.27 | 2.5 | 1.78 | 0.12 | 0.11 | Upgrade
|
| Total Common Shares Outstanding | 4.27 | 4.27 | 2.5 | 0.75 | 0.12 | 0.11 | Upgrade
|
| Working Capital | 4.11 | 12.22 | 19.28 | 5.62 | 1.08 | 1.2 | Upgrade
|
| Book Value Per Share | 1.27 | 3.37 | 8.49 | 10.46 | -318.03 | -301.96 | Upgrade
|
| Tangible Book Value | 5.44 | 14.41 | 21.19 | 7.86 | -37.07 | -34.66 | Upgrade
|
| Tangible Book Value Per Share | 1.27 | 3.37 | 8.49 | 10.46 | -318.03 | -301.96 | Upgrade
|
| Machinery | - | 1.16 | 0.99 | 1.39 | 1.33 | 1.22 | Upgrade
|
| Leasehold Improvements | - | - | - | 0.85 | 0.85 | 0.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.